Vistagen Therapeutics (VTGN) Operating Leases (2019 - 2026)
Vistagen Therapeutics' Operating Leases came in at $63,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 92.0% from $783,000 a year earlier and down 74.7% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Operating Leases was $249,000, down 73.7% from FY2025.
- Operating Leases has declined in each of the last six fiscal years, with a five-year compound annual growth rate of -40.5% (FY2021 to FY2026).
- Going back by fiscal year, Operating Leases was $948,000 in FY2025 (-39.6%), $1.57 million in FY2024 (-25.9%), $2.12 million in FY2023 (-18.6%) and $2.61 million in FY2022 (-22.2%).
- The fiscal Q1 2027 figure represents the lowest quarterly Operating Leases in data going back to fiscal Q1 2020.
- Year-over-year, Operating Leases has declined for 25 consecutive quarters, with an average decline of 53.8% over the last eight quarters.
- Across the past five years, year-over-year decline in Operating Leases ran from 11.3% in fiscal Q2 2022 to 92.0% in fiscal Q1 2027.
- Business Quant data shows VTGN's Operating Leases at $249,000 (Q4 2026), $431,000 (Q3 2026) and $610,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,000.00 |
| Mar 31, 2026 | 249,000.00 |
| Dec 31, 2025 | 431,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Jun 30, 2025 | 783,000.00 |
| Mar 31, 2025 | 948,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 2.49 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 2.72 Mn |
| Sep 30, 2021 | 3.14 Mn |
API Access
Vistagen Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();